NEW YORK (GenomeWeb News) — Belgian biopharmaceutical company UCB is using two of Genedata's software platforms to support its drug-development programs, Genedata said today.
 
Genedata said UCB has deployed the integrated Phylosopher and Expressionist software platforms. The drug maker will use the platforms to study CNS disorders, allergy and respiratory diseases, immune and inflammatory disorders, and oncology.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.